BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36924631)

  • 1. Development and validation of a multiplexed assay for the measurement of long-acting hormonal contraceptives in plasma via liquid chromatography-tandem mass spectrometry.
    Knezevic CE; Parsons TL; Gollings R; Pandey A; Marzinke MA
    J Pharm Biomed Anal; 2023 May; 228():115321. PubMed ID: 36924631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma.
    Garza KY; Pandey A; Marzinke MA
    J Pharm Biomed Anal; 2023 Oct; 235():115629. PubMed ID: 37619293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high resolution LC-MS targeted method for the concomitant analysis of 11 contraceptive progestins and 4 steroids.
    Laszlo CF; Paz Montoya J; Shamseddin M; De Martino F; Beguin A; Nellen R; Bruce SJ; Moniatte M; Henry H; Brisken C
    J Pharm Biomed Anal; 2019 Oct; 175():112756. PubMed ID: 31387028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New knowledge in the physiology of hormonal contraceptives.
    Lobo RA; Stanczyk FZ
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1499-507. PubMed ID: 8178898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of sensitive LC/MS/MS method for quantitative bioanalysis of levonorgestrel in rat plasma and application to pharmacokinetics study.
    Ananthula S; Janagam DR; Jamalapuram S; Johnson JR; Mandrell TD; Lowe TL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1003():47-53. PubMed ID: 26409262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.
    Skosana SB; Woodland JG; Cartwright M; Enfield K; Komane M; Louw-du Toit R; van der Spuy Z; Avenant C; Africander D; Storbeck KH; Hapgood JP
    J Steroid Biochem Mol Biol; 2019 May; 189():145-153. PubMed ID: 30822501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantitation of multiple contraceptive hormones in human serum by LC-MS/MS.
    Blue SW; Winchell AJ; Kaucher AV; Lieberman RA; Gilles CT; Pyra MN; Heffron R; Hou X; Coombs RW; Nanda K; Davis NL; Kourtis AP; Herbeck JT; Baeten JM; Lingappa JR; Erikson DW
    Contraception; 2018 Apr; 97(4):363-369. PubMed ID: 29407362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of an expanded panel of progestins using liquid chromatography-tandem triple quadrupole mass spectrometry to monitor protocol compliance in hormonal contraceptive pharmacokinetic/pharmacodynamic studies.
    Jensen JT; Waites BT; Boniface ER; McCrimmon S; Blue S; Erikson DW
    Contraception; 2023 Oct; 126():110130. PubMed ID: 37499736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous online SPE-LC-MS/MS quantification of six widely used synthetic progestins in human plasma.
    Moser C; Zoderer D; Luef G; Rauchenzauner M; Wildt L; Griesmacher A; Seger C
    Anal Bioanal Chem; 2012 May; 403(4):961-72. PubMed ID: 22160205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
    Huijbregts RP; Michel KG; Hel Z
    Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma.
    Cirrincione LR; Penchala SD; Scarsi KK; Podany AT; Winchester LC; Back DJ; Khoo SH; Fletcher CV; Siccardi M; Else LJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():106-112. PubMed ID: 29579732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
    Buckner LR; Drobnis EZ; Augustine MS; Rogers LK; Akers J; Mott PD; Hope TJ; Quayle AJ; Schust DJ
    PLoS One; 2019; 14(5):e0214152. PubMed ID: 31095572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of cabotegravir and rilpivirine from dried blood spots.
    Weld ED; Parsons TL; Gollings R; McCauley M; Grinsztejn B; Landovitz RJ; Marzinke MA
    J Pharm Biomed Anal; 2023 May; 228():115307. PubMed ID: 36842333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial.
    Jensen JT; Edelman A; Westhoff CL; Schreiber CA; Archer DF; Teal S; Thomas M; Brown J; Blithe DL
    Contraception; 2024 Apr; ():110475. PubMed ID: 38670302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a liquid chromatographic-tandem mass spectrometric method for the multiplexed quantification of etravirine, maraviroc, raltegravir, and rilpivirine in human plasma and tissue.
    Parsons TL; Marzinke MA
    J Pharm Biomed Anal; 2016 Nov; 131():333-344. PubMed ID: 27632783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestin-only contraceptives: effects on weight.
    Lopez LM; Ramesh S; Chen M; Edelman A; Otterness C; Trussell J; Helmerhorst FM
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008815. PubMed ID: 27567593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestin-only contraceptives: effects on weight.
    Lopez LM; Edelman A; Chen M; Otterness C; Trussell J; Helmerhorst FM
    Cochrane Database Syst Rev; 2013 Jul; 7(7):CD008815. PubMed ID: 23821307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches for developing biomarkers of hormonal contraceptive use.
    Sachdeva R; Kumar N; Brache V; Friedland BA; Plagianos M; Zhang S; Kizima L; Cochon L; Tabar AST; Blanc A; Merkatz RB
    Sci Rep; 2023 Jan; 13(1):245. PubMed ID: 36604469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN.
    Avenant C; Bick AJ; Skosana SB; Dlamini S; Balakrishna Y; Moliki JM; Singata-Madliki M; Hofmeyr GJ; Smit J; Beksinska M; Beesham I; Seocharan I; Batting J; Chen PL; Storbeck KH; Africander D; Hapgood JP
    PLoS One; 2023; 18(12):e0295959. PubMed ID: 38134043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.